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Abstract
Kawasaki disease (KD) is characterized by systemic vasculitis with unknown etiology. Previous studies from Japan indicated
that a gene polymorphism of ITPKC (rs28493229) is responsible for susceptibility to KD. We collected DNA samples from
1,531 Taiwanese subjects (341 KD patients and 1,190 controls) for genotyping ITPKC. In this study, no significant association
was noted for the ITPKC polymorphism (rs28493229) between the controls and KD patients, although the CC genotype was
overrepresented. We further combined our data with previously published case/control KD studies in the Taiwanese
population and performed a meta-analysis. A significant association between rs28493229 and KD was found (Odds
Ratio:1.36, 95% Confidence Interval 1.12–1.66). Importantly, a significant association was obtained between rs28493229 and
KD patients with aneurysm formation (P=0.001, under the recessive model). Taken together, our results indicated that C-
allele of ITPKC SNP rs28493229 is associated with the susceptibility and aneurysm formation in KD patients in a Taiwanese
population.
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Introduction
Kawasaki disease (KD) is a multi-systemic vasculitis with
unknown etiology which was first reported by Kawasaki et al.
[1] from Japan in 1974 in the English language literature. It occurs
worldwide and mainly affects children less than 5 years old
especially in Asian countries, Japan, Korea and Taiwan with the
incidence from 69 to 213 cases per 100000 for children ,5 years
of age [2,3]. The clinical characteristics of KD include prolonged
fever, bilateral non-purulent conjunctivitis, diffuse mucosal
inflammation, polymorphous skin rashes, indurative angioedema
of the hands and feet, and non-suppurative cervical lymphade-
nopathy [3,4]. The most serious complication of KD is coronary
artery lesions (CAL) including myocardial infarction, coronary
artery dilatation, coronary fistula or coronary artery aneurysm
[5,6]. In developed countries, KD is the leading cause of acquired
heart diseases in children.
While these clinical features of KD are recognized, their
underlying immunopathogenic mechanisms are still unclear; in
particular, the culprit for developing CAL in patients with KD
remains as yet to be uncovered. KD is regarded as an immune
disorder of host rather than an infectious disease. From our
previous reports, monocytosis and T helper 2 (Th2) immune
response were associated with CAL formation [6,7], and
intravenous immunoglobulin (IVIG) treatment response in KD
[8]. These results highlight the involvement of dysregulated
immune response in the pathogenesis of KD.
Genetic association of KD with inositol 1,4,5-trisphosphate
3-kinase C (ITPKC) in a genome wide scan has been recently
reported by Onouchi et al. They first indicated a functional SNP
in the ITPKC gene associated with KD susceptibility and the
development of coronary artery lesions [9]. The polymorphism of
ITPKC (rs28493229) located in intron 1 that resulted in the
different transcriptional level of mature mRNA by interfering the
RNA splicing efficiency. ITPKC is a kinase that phosphorylates
inositol 1,4,5-trisphosphate (IP3). IP3 is an important factor in the
initiating of calcium release from endoplasmic reticulum [10].
The empty of endoplasmic further evokes store-operated
calcium influx. Store-operated calcium influx has been shown to
involve in the activation of T cells. For example, IP3-mediated
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nuclear factor of activated T-cells (NFAT) that further evoked the
release of cytokines and the initiation of immune responses [10].
ITPKC is a negative regulator of Ca
2+/NFAT signaling pathways.
High level expression of ITPKC can attenuate the Ca
2+/NFAT
pathways via over phosphorylation of IP3 that resulted in
reduction of T cell activation and IL-2 production. ITPKC
(rs28493229) was confirmed to associate with the susceptibility of
Kawasaki disease and CAL formation. However, the replication
studies of ITPKC (rs28493229) from Taiwanese populations were
controversial [11,12].
In this study, we examined the association between the ITPKC
(rs28493229) and the risk of KD using a case-control study. The
relationship of clinical data including CAL, intravenous immuno-
globulin (IVIG) treatment response, and aneurysm formation with
genetic polymorphisms of ITPKC were also evaluated.
Materials and Methods
Patients studied
All subjects studied were children with the diagnosis of KD and
were admitted at Chang Gung Memorial Hospital at Kaohsiung
between 2001 and 2009. All patients were treated with a single
infusion of IVIG (2 g/kg) administered over a 12-hour period.
Aspirin (3–5 mg/kg/day) was administered until all signs of
inflammation were resolved or regression of CAL was detected
under two-dimensional (2D) echocardiography; these conditions
were the same as that in our previous studies [6,7,8,13,14,]. We
excluded patients who did not meet the diagnostic criteria for KD.
CAL was defined by the internal diameter of the coronary artery
being at least 3 mm (4 mm, if the subject was over the age of 5
years) or the internal diameter of a segment being at least 1.5 times
that of an adjacent segment, as observed in the echocardiogram
[15,16,17]. KD patients with coronary artery ectasia or dilatation
which was disappearing within the initial 2 months after the onset
of illness were defined as transient ectasia (or transient CAL) and
not judged as CAL. IVIG responsiveness was defined as
defervescence 48 h after the completion of IVIG treatment and
no fever (temperature, .38uC) recurrence for at least 7 days after
IVIG with marked improvement or normalization of inflamma-
tory signs. A total of 1190 control subjects were recruited from the
general population who volunteered to participate in our study
while receiving a health screening examination at the Kaohsiung
Medical University Hospital. All the subjects gave the consent
form. The study protocol conformed to the Declaration of Helsinki
and study was approved by the Institute Review Board of
Hospital.
DNA extraction
Blood cells were subjected to DNA extraction by treating them
first with 0.5% SDS lysis buffer and then protease K (1 mg/ml) for
digestion of nuclear protein for 4 h at 60uC. Total DNA was
harvested by using the Gentra extraction kit followed by 70%
alcohol precipitation.
Genotyping
Genomic DNA was extracted from whole blood samples by
using the standard method. Genotyping was carried out using the
TaqMan Allelic Discrimination Assay (Applied Biosystems, Foster
city, CA). Briefly, the polymerase chain reaction (PCR) was
performed by using a 96-well microplate with the ABI 9700
Thermal Cycler. The thermal cycle conditions were as follows:
denaturing at 95uC for 10 min, followed by 40 cycles of
denaturing at 92uC for 15 s and annealing and extension at
60uC for 1 min. After PCR, fluorescence was measured and
analyzed using the System SDS software version 1.2.3. Average
genotyping successful rate in our lab is around 95.7%, so some
individuals are without genotype data.
Statistical analysis
SAS 9.1 for Windows was used for analysis. The statistical
differences between cases and controls in genotype and allele
frequency were assessed by the x
2-test or the Fisher exact test. The
statistical differences in the genotype and allele frequency of KD
patients with and those without CAL formation and patients
responding to IVIG and those showing resistance were assessed
using the x
2-test. For the meta-analysis, sufficient data were
available from other two KD association studies, and the odds
ratios with 95% confidence intervals were calculated for the risk
factors investigated. Combined odds ratios were calculated using
Mantel–Haenszel method with a fixed effect model for each
outcome measure. Statistical analysis was completed using the
rmeta package of R software.
Table 1. Basal characteristics of patients with Kawasaki
disease (KD) and of normal controls.
Characteristics Patients with KD Normal Control
Number of subjects 341 1190
Gender: male, No (%) 226 (66.3%) 681 (57.2%)
Age (years) 1.661.4 26.0622.6
Range 3.5-144 (months) 1–85 (years)
Coronary artery lesions (CAL) 35 (10.3%)
Aneurysm formation 14 (4.1%)
Intravenous immunoglobulin
(IVIG) resistant
43 (12.6%)
CAL: coronary artery lesions; IVIG: intravenous immunoglobulin; SD: standard
deviation.
doi:10.1371/journal.pone.0017370.t001
Table 2. Genotype frequencies for ITPKC SNP and Kawasaki disease susceptibility.
Geno-
type
Case (%)
(n=334)
Control Subjects
(%) (n=1131) Allele
Case (%)
(n=334)
Control Subjects
(%) (n=1131)
Genotype
P Value
Dominant
P Value
Recessive
P Value
Allelic
P Value
rs28493229 CC 2 (0.6) 8 (0.7) C 54 (8.1) 158 (7.0) 0.509 0.283 0.832 0.335
CG 50 (15.0) 142 (12.6) G 614 (91.9) 2104 (93.0) 0.062
{ 0.891
{ 0.065
{
GG 282 (84.4) 981 (86.7)
{Adjusted the effects of age and gender.
doi:10.1371/journal.pone.0017370.t002
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Meta-analysis shows that ITPKC SNP rs28493229 is
associated with the susceptibility of KD
Table 1 shows the characteristics of the subjects. A total of
341 KD patients and 1190 controls were recruited in this study.
66.3% of cases and 57.2% of controls were male. The mean age of
patients and controls was 1.661.4 months (standard deviation
[SD]) and 26.0622.6 years, respectively. Children were predom-
inant in the study population, an observation that is in agreement
with the reported incidence of KD. The prevalence of KD is less
than 1/1,000 children in Taiwan. Therefore, we assumed that
there was no KD case in the control group. There were 10.3% of
KD with CAL formation, and 4.1% with aneurysm formation.
Among these KD patients 12.6% were resistant to initial IVIG
treatment. The distribution of ITPKC SNP genotypes was in
accordance with the Hardy-Weinberg equilibrium for both cases
and controls (Table 2). However, the SNP tested in this study
doesn’t show a significant association with KD under three genetic
models (Dominant model; Recessive model and Allelic model). To
assess the role of variation in ITPKC SNP rs28493229 more
extensively, we therefore performed a meta-analysis on all
published KD association studies in the Taiwanese population
including the present data. The results showed a significant
association between ITPKC SNP rs28493229 and the susceptibility
of KD (OR=1.36, 95% CI 1.12–1.66) in the Taiwanese
population (Figure 1).
No association between ITPKC SNP rs28493229 and CAL
formation or IVIG treatment response in KD patients
A total of 341 KD patients were included in this study, of which
35 patients (10.3%) had CAL formation and 43 patients (12.6%)
were resistant to initial IVIG treatment (Table 1). We further
evaluate the relationship between rs28493229 and the risk of CAL
formation or IVIG resistance. The data is shown in Table 3 and
Table 4, respectively. The frequency of C allele was higher in the
patients with CAL formation (10.3% vs. 7.6%) or IVIG resistance
(11.6% vs. 7.6). However, the genotype or allele frequency of
rs28493229 still failed to reach any significant association with
CAL formation or IVIG resistance.
SNP rs28493229 of ITPKC significant associated with
aneurysm formation in KD
We further identify the role of SNP rs28493229 of ITPKC in the
pathogenesis of CAL in KD patients. A subset analysis where cases
reported having aneurysm formation was performed. In this study,
14 patients (4.1%) had aneurysm formation (aneurysm was defined
Table 3. Genotyping and allele frequency of ITPKC SNP in patients with Coronary artery lesion (CAL) and without CAL.
Geno-
type
CAL (%)
(n=34)
Without (%)
(n=295) Allele
CAL (%)
(n=34)
Without (%)
(n=295)
Genotype
P Value
Dominant
P Value
Recessive
P Value
Allelic
P Value
Rs28493229 CC 1 (2.9) 1 (0.3) C 7 (10.3) 45 (7.6) 0.181 0.674 0.065 0.440
CG 5 (14.7) 43 (14.6) G 61 (89.7) 545 (92.4)
GG 28 (82.4) 251 (85.1)
doi:10.1371/journal.pone.0017370.t003
Figure 1 Forest Plots. (A) Depicting the association between KD patients and controls. (B) Allele frequency of rs28493229 in KD patients and
controls in different cohortsfrom Taiwan.
doi:10.1371/journal.pone.0017370.g001
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internal diameter of a segment being at least 1.5 times that of an
adjacent segment and that was persistent after at least one year
followed up) (Table 1). As shown in the Table 5, SNP rs28493229
of ITPKC was associated with the KD patients with aneurysm
formation. KD patients carry rs28493229 homozygous C/C
genotype had a 24.5-fold (P=0.001) increased risk of aneurysm
formation when compared with those with C/G and G/G
genotypes.
Discussion
Kawasaki disease is an acute vasculitis that may lead to acquired
coronary artery aneurysms. Many genetic factors have been
reported to involve in the development of coronary artery
aneurysms. A major advance came when Onouchi et al.
performed a large scale of genome wide screening to study the
polymorphisms in KD patients [9]. They found that C allele of
ITPKC (rs28493229) that reduced the expression of ITPKC
associated with KD susceptibility and formation of coronary artery
lesions from Japan and US cohort. Not only did it indicated that
genetic factors contributed to the susceptibility as well as the
pathogenesis of KD, but this was the first unequivocal identifica-
tion of the functional SNP in a new gene (ITPKC). However, the
replication studies of ITPKC (rs28493229) from Taiwanese
populations were with controversial results. Chi et al. [11], didn’t
find any statistically significant association between the ITPKC
SNP rs28493229 and KD susceptibility or CALs in Taiwanese
children. Interestingly, reports from Lin et al. [12], indicated that
C-allele of ITPKC SNP rs28493229 is associated with KD
susceptibility and BCG scar reactivation during the acute phase
but not associated with the develop or severity of CAL formation.
As shown in Table 2, although rs28493229 didn’t have significant
association with the KD, higher C allele frequency in KD cases
(8.1% vs 7.0%) was seen in this study. To increase the analysis
power, we therefore performed a meta-analysis on all published
KD association studies in the Taiwanese population. Consistent
with the first ITPKC studies by Onouchi [11,12], results from
meta-analysis strongly indicated that C allele of ITPKC
rs28493229 is a risk allele in the KD susceptibility in the
Taiwanese population. In this study, we also first analysis the
association between rs28493229 with IVIG treatment response
and aneurysm formation. Our results indicated that C allele of
ITPKC rs28493229 had significant higher risk to have aneurysm
formation. Although the exact role of ITPKC in the development
of KD is unclear, it may function as the negative regulator in the
regulation of immune genes or to be involved in the T cell
activation mechanisms. The results also, at least, reflect the facts
that complex genetic, ethnic, and environmental factors are
involved in the association with KD [11,12]. Regarding to the
different results obtained for ITPKC genetic association studies in
the Taiwanese population, we attribute this to the population
migration between Taiwan and China, Thailand, Indonesia,
Malaysia, Vienna and other Asia areas, due to the increase of
genetic diversity between cities in the south or north of Taiwan.
ITPKC is able to effect cellular expression level of IP3 via
phosphorylation steps. Two possible signaling pathways that may
involve in the increase of intracellular calcium concentration can
be triggered by IP3. First, upon binding to the IP3 receptor (IP3R)
on the endoplasmid reticulum, IP3 triggers the release of
intracellular calcium from stores. Second, store empty resulted in
the activation of STIM1-mediated store-operated calcium chan-
nels. Both calcium releases from stores or calcium influx through
store-operated calcium channels have been confirmed to initiate
signaling pathways to regulate inflammatory cytokines and
immune diseases. In T-cells, agents block calcium influx through
store-operated calcium channel attenuated the translocation of
NFAT or NFkB and the expression of immune related genes [18].
The polymorphism of ITPKC (C allele) exhibited lower gene
expression that may result in the increase of global intracellular
calcium concentration via IP3-mediated pathways. Over-activa-
tion of calcium-dependent inflammatory cytokines may damage
coronary vessel wall and cause to the aneurysm formation. Our
results implied that C-allele of ITPKC SNP rs28493229 may
passively increase the activation of calcium-dependent signaling
pathways that lead to aneurysm formation in KD patients.
KD is considered as one of the immune-mediated diseases.
Several genes have been reported to be associated with
Table 5. Genotyping and allele frequency of ITPKC SNP in patients with aneurysm or without aneurysm.
Geno-
type
Aneurysm
(%) (n=14)
Without
(%) (n=320) Allele
Aneurysm
(%) (n=14)
Without
(%) (n=320)
Genotype
P Value
Dominant
P Value
Recessive
P Value
Allelic
P Value
Rs28493229 CC 1 (7.1) 1 (0.3) C 3 (10.7) 51 (8.0) 0.004* 0.892 0.001* 0.602
CG 1 (7.1) 49 (15.3) G 25 (89.3) 589 (92.0)
GG 12 (85.8) 270 (84.4)
*Significant (P,0.05) values are in bold.
doi:10.1371/journal.pone.0017370.t005
Table 4. Genotyping and allele frequency of ITPKC SNP in patients with resistant and responsive to Intravenous immunoglobulin
(IVIG) treatment.
Geno-
type
Resistant (%)
(n=43)
Responsive
(%) (n=291) Allele
Resistant
(%) (n=43)
Responsive
(%) (n=291)
Genotype
P Value
Dominant
P Value
Recessive
P Value
Allelic
P Value
Rs28493229 CC 0 (0.0) 2 (0.7) C 10 (11.6) 44 (7.6) 0.266 0.159 0.581 0.226
CG 10 (23.3) 40 (13.7) G 76 (88.4) 538 (92.4)
GG 33 (76.7) 249 (85.6)
doi:10.1371/journal.pone.0017370.t004
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CASP3, CTLA4, TGF-beta pathways and MMP family… etc
[9,16,19,20,21,22,23]. Genes of ITPKC and CASP3 are involved
in the Ca
2+/NFAT pathways. These two genes have been shown
to associate with susceptibility to KD in the Japanese and
European Americans. Consistent with this, we did observe a
significant association in the KD patients with aneurysm formation
even though the allele frequency is low. What might be the
relevance of our findings to the KD? KD patients who are resistant
with initial IVIG therapy have higher risk of developing CAL or
aneurysm formation. Many inhibitors for Ca
2+/NFAT pathways
are already in the clinical use. From pharmacology prospective, to
identify novel inhibitors against Ca
2+/NFAT pathways seems to
be promising in the treatment of KD. Further pharmacogenomic
studies to confirm to the effects of inhibitors for Ca
2+/NFAT
pathways such as Cyclosporine A in the IVIG resistant patients
may should be considered.
In conclusion, we reported that ITPKC (rs28493229) had
significant association with the susceptibility of KD in the
Taiwanese population. Importantly, KD patients carry ITPKC
rs28493229 C allele had significant higher risk to have aneurysm
formation.
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